Speciality Medicines Ltd
Listed
BSE SME
SME
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
150,000
6.38% |
6.38%
|
₹1.86 |
|
QIB
|
Over 1.00x
|
21,000
0.89% |
0.89%
|
₹0.26 |
|
NII / HNI
|
Over 1.00x
|
1,089,000
46.34% |
46.34%
|
₹13.50 |
|
Retail
|
Over 1.00x
|
1,090,000
46.38% |
46.38%
|
₹13.52 |
| Total | 1.00x | 2,350,000 |
100% | ₹29.14 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 21,000 | ₹0.26 |
0.89%
|
| Market Maker | 150,000 | ₹1.86 |
6.38%
|
| NII | 1,089,000 | ₹13.50 |
46.34%
|
| Retail | 1,090,000 | ₹13.52 |
46.38%
|
| Total | 2,350,000 | ₹29.14 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 1,089,000 | 1,090,000 | 2,179,000 |
| Allotment price (₹) | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹13.52 | ₹13.52 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 1,089,000 | 1,090,000 | 2,179,000 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 2,000 | ₹248,000 |
| Retail (Max — 13 Lots) | 13 | 13,000 | ₹1,612,000 |
| S-HNI (Min — 14 Lots) | 14 | 14,000 | ₹1,736,000 |
| B-HNI (Min — 68 Lots) | 68 | 68,000 | ₹8,432,000 |
Speciality Medicines Ltd is proposing an IPO on BSE SME under the SME category. Total issue: 23,50,000 shares (agg. up to ₹29 Cr).
Opens 20 Mar 2026, closes 24 Mar 2026. Listing: 30 Mar 2026. Apply via ASBA or UPI.
| Particulars | 31 Oct 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 36.93 | 58.54 | 27.66 |
| EBITDA | 6.51 | 9.09 | 5.26 |
| Profit After Tax (PAT) | 6.06 | 8.61 | 2.93 |
| Net Worth | 36.47 | 30.42 | 15.06 |
| Total Assets | 45.57 | 39.98 | 22.68 |
| Reserves & Surplus | 30.04 | 23.98 | 9.95 |
| Borrowings | 4.81 | 5.05 | 2.86 |
| EBITDA Margin (%) | 17.73% | — | — |
| PAT Margin (%) | 16.49% | — | — |
Speciality Medicines Ltd IPO is subscribed 1.00 times by Mar 24, 2026. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Speciality Medicines Ltd IPO retail category is subscribed 1.00 times as of 24 Mar 2026. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 20 Mar 2026 and closes 24 Mar 2026. Min investment: ₹124,000 (1 lot = 1,000 shares). UPI mandate: 5:00 PM on 24 Mar 2026.
The Speciality Medicines Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 30 Mar 2026. Refunds: on 31 Mar 2026.
The Speciality Medicines Ltd IPO listing date is 30 Mar 2026, Monday. Listed on: BSE SME. Issue price: ₹124. Estimated listing: ₹124. GMP: NIL.
The Speciality Medicines Ltd IPO closes on 24 Mar 2026, Tuesday. UPI mandate: 5:00 PM on 24 Mar 2026. Allotment: 30 Mar 2026. Listing: 30 Mar 2026.